top of page
Executive Spotlights

Neumora Therapeutics Appoints Henry Gosebruch as CEO to Lead Neuroscience Revolution

Watertown, MA, July 18, 2023 (Business Wire) -- Neumora Therapeutics, a biopharmaceutical company focused on transforming neuroscience drug development, welcomes Henry Gosebruch as the new President and CEO. With a proven track record in the pharmaceutical industry, most recently as the EVP and Chief Strategy Officer at AbbVie, Gosebruch will drive Neumora's vision of becoming a leader in brain health and pioneering novel therapies for CNS disorders.

Read full article here.

Recent Posts

See All

AxoSim appoints Alif Saleh as CEO

New Orleans, LA, June 14, 2024 (Indian Pharma Post) -- AxoSim, a life science firm specializing in lab-grown human brains, has appointed Alif Saleh as its new CEO. Salef, a company builder, brings e


Life Science Headlines
bottom of page